MorphaBond ER Approval History
FDA Approved: Yes (First approved October 2, 2015)
Brand name: MorphaBond ER
Generic name: morphine sulfate
Dosage form: Extended-Release Tablets
Company: Inspirion Delivery Sciences
Treatment for: Pain
MorphaBond ER (morphine sulfate) is an extended-release, abuse-deterrent, opioid analgesic for the treatment of pain severe enough to require daily, around-the-clock, long-term opioid treatment.
Development History and FDA Approval Process for MorphaBond ER
|Oct 5, 2015||FDA Approves MorphaBond (morphine sulfate) Extended-Release Tablets with Abuse-Deterrent Properties|
|Feb 9, 2015||Inspirion Delivery Technologies Announces FDA Acceptance of MorphaBond ER (morphine sulfate extended-release) NDA|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.